aripiprazole versus risperidone for treating schizophrenia
Phase 2
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT201305233930N26
- Lead Sponsor
- Shiraz University of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with schizophrenia aged between 16 to 65 years old.
Exclusion criteria: serious uncontrolled medical condition such as hypothyroidism; pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: baseline and at the end of this trial. Method of measurement: kilogram.;Height. Timepoint: Baseline and at the end of this trial. Method of measurement: Meter.
- Secondary Outcome Measures
Name Time Method